会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MODULAR TRANSPORT PLATFORM FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
    • 用于定向递送治疗药物的模块化运输平台
    • WO2012160450A2
    • 2012-11-29
    • PCT/IB2012/050624
    • 2012-02-13
    • CONTANGO PARTNERS GROUP, INC.SOBOLEV, Alexander, S.ROSENKRANZ, Audrey, A.JANS, David, A.LUNIN, Vladimir, G.
    • SOBOLEV, Alexander, S.ROSENKRANZ, Audrey, A.JANS, David, A.LUNIN, Vladimir, G.
    • A61K47/48269A61K41/0071A61K47/6415A61K47/642A61K47/6445A61K51/081A61K51/088
    • The invention relates to a modular transport platform (MTP) for delivering active, diagnostic or research substances to predesigned intracellular compartments of target cells. The MTP includes functional modules within one molecule to accomplish one or more of the following: penetration of the modular transport platform into a target cell type, pH-dependent membrane disruption activity within the target cell, directed intracellular transport into preselected intracellular compartment, and delivery of a substance to be transported to the intracellular compartment. The modular transport platform includes the following modules: (1) a ligand module to target a specific receptor on the surface of the target cell; (2) an endosomolytic module that provides pH-dependent membrane disruption activity within the target cell; (3) an intracellular transport module to cause delivery of the MTP to a particular subcellular compartment; (4) a module for intracellular retention to ensure retention of the MTP within the subcellular compartment of the target cell; (5) a module for subcellular recognition; (6) a substance to be transported by the MTP; and (7) a carrier module for unifying the modules and coupling the modules with the transported substance.
    • 本发明涉及用于将活性,诊断或研究物质递送到靶细胞的预先设计的细胞内区室的模块化转运平台(MTP)。 MTP包括一个分子内的功能模块,以实现以下一个或多个:模块化传输平台渗透到靶细胞类型中,靶细胞内的pH依赖性膜破坏活性,定向细胞内转运到预选的细胞内区室和递送 的物质被运送到细胞内隔室。 模块化运输平台包括以下模块:(1)靶靶细胞表面上特定受体的配体模块; (2)在靶细胞内提供pH依赖性膜破坏活性的内体分解模块; (3)细胞内转运模块,以使MTP递送至特定的亚细胞室; (4)用于细胞内保留的模块以确保MTP在靶细胞的亚细胞间隔内的保留; (5)用于亚细胞识别的模块; (六)中期计划运输的物质; 和(7)用于统一模块并将模块与输送的物质耦合的载体模块。
    • 2. 发明申请
    • MODULAR TRANSPORT PLATFORM FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
    • 用于定向递送治疗药物的模块化运输平台
    • WO2012160450A3
    • 2013-01-17
    • PCT/IB2012050624
    • 2012-02-13
    • CONTANGO PARTNERS GROUP INCSOBOLEV ALEXANDER SROSENKRANZ AUDREY AJANS DAVID ALUNIN VLADIMIR G
    • SOBOLEV ALEXANDER SROSENKRANZ AUDREY AJANS DAVID ALUNIN VLADIMIR G
    • A61K47/48A61K41/00A61K51/08A61P35/00
    • A61K47/48269A61K41/0071A61K47/6415A61K47/642A61K47/6445A61K51/081A61K51/088
    • The invention relates to a modular transport platform (MTP) for delivering active, diagnostic or research substances to predesigned intracellular compartments of target cells. The MTP includes functional modules within one molecule to accomplish one or more of the following: penetration of the modular transport platform into a target cell type, pH-dependent membrane disruption activity within the target cell, directed intracellular transport into preselected intracellular compartment, and delivery of a substance to be transported to the intracellular compartment. The modular transport platform includes the following modules: (1) a ligand module to target a specific receptor on the surface of the target cell; (2) an endosomolytic module that provides pH-dependent membrane disruption activity within the target cell; (3) an intracellular transport module to cause delivery of the MTP to a particular subcellular compartment; (4) a module for intracellular retention to ensure retention of the MTP within the subcellular compartment of the target cell; (5) a module for subcellular recognition; (6) a substance to be transported by the MTP; and (7) a carrier module for unifying the modules and coupling the modules with the transported substance.
    • 本发明涉及用于将活性,诊断或研究物质递送到靶细胞的预先设计的细胞内区室的模块化转运平台(MTP)。 MTP包括一个分子内的功能模块,以实现以下一个或多个:模块化传输平台渗透到靶细胞类型中,靶细胞内的pH依赖性膜破坏活性,定向细胞内转运到预选的细胞内区室和递送 的物质被运送到细胞内隔室。 模块化运输平台包括以下模块:(1)靶靶细胞表面上特定受体的配体模块; (2)在靶细胞内提供pH依赖性膜破坏活性的内体分解模块; (3)细胞内转运模块,以使MTP递送至特定的亚细胞室; (4)用于细胞内保留的模块以确保MTP在靶细胞的亚细胞间隔内的保留; (5)用于亚细胞识别的模块; (六)中期计划运输的物质; 和(7)用于统一模块并将模块与输送的物质耦合的载体模块。